Humoral and cellular immunity to varicella-zoster virus: An overview

Journal of Infectious Diseases

Volumn 197, Issue SUPPL. 2, 2008, Pages

  Arvin, Ann M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CHICKENPOX VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LIVE VACCINE;

CELLULAR IMMUNITY; CHICKENPOX; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; HERPES ZOSTER; HISTOCOMPATIBILITY COMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; INCUBATION TIME; INNATE IMMUNITY; NATURAL KILLER CELL; NATURAL KILLER T CELL; PRIORITY JOURNAL; VARICELLA ZOSTER VIRUS;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHICKENPOX; CHILD; CHILD, PRESCHOOL; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNITY, CELLULAR;

EID: 42549121665     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/522123     Document Type: Conference Paper

References (27)

1. Arvin AM. Varicella-zoster virus. In: Knipe DM, Howley P, eds. Fields' virology, 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001: 2731-68.
2. Ihara T, Kato T, Torigoe S, et al. Antibody response determined with antibody-dependent cell-mediated cytotoxicity (ADCC), neutralizing antibody, and varicella skin test in children with natural varicella and after varicella immunization. Acta Paediatr Jpn 1991; 33:43-9.
3. Arvin AM, Kushner JH, Feldman S, et al. Human leukocyte interferon for treatment of varicella in children with cancer. N Engl J Med 1982; 306:761-7.
4. Ku C-C, Zerboni L, Besser J, Ito H, Arvin AM. Varicella-zoster virus transfer to skin by T cells and modulation of viral replication by epidermal cell interferon-α. J Exp Med 2004; 200:917-25.
5. Abendroth A, Slobedman B, Eunice L, Mellins E, Wallace M, Arvin AM. Modulation of MHC class II protein expression by varicella zoster virus. J Virol 2000; 74:1900-7.
6. Abendroth A, Lin I, Slobedman B, Ploegh H, Arvin AM. Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells. J Virol 2001; 75:4878-88.
7. Arvin AM, Koropchak CM, Williams BR, Grumet FC, Foung SK. Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J Infect Dis 1986; 154:422-9.
8. Arvin A. Varicella-zoster virus: virologic and immunologic aspects of persistent infection. In: Ahmed R, Chen I, eds. Persistent viral infections. New York: John Wiley & Sons, 1998:183-208.
9. Gershon AA, Mervish N, LaRussa P, et al. Varicella-zoster virus infection in children with underlying human immunodeficiency virus infection. J Infect Dis 1997; 176:1496-500.
10. Diaz PS, Smith S, Hunter E, Arvin AM. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine. J Immun 1989; 142:636-41.
11. Arvin AM, Sharp M, Smith S, et al. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype. J Immunol 1991; 146:257-64.
12. Webster AD, Spickett GP, Thomson BJ, Farrant J. Viruses and antibody deficiency syndromes. Immunol Invest 1988; 17:93-105.
13. Hayward AR, Pontesilli O, Herberger M, Laszlo M, Levin M. Specific lysis of varicella zoster virus-infected B lymphoblasts by human T cells. J Virol 1986; 58:179-84.
14. Jenkins DE, Redman RL, Lam EM, Liu C, Lin I, Arvin AM. Interleukin (IL)-10, IL-12, and interferon-γ production in primary and memory immune responses to varicella-zoster virus. J Infect Dis 1998; 178:940-8.
15. Huang Z, Vafai A, Lee J, Mahalingam R, Hayward AR. Specific lysis of targets expressing varicella-zoster virus gpI or gpIV by CD4+ human T-cell clones. J Virol 1992; 66:2664-9.
16. Asanuma H, Sharp M, Maecker HT, et al. Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus and cytomegalovirus determined by intracellular detection of cytokine expression. J Infect Dis 2000; 181:859-66.
17. Sharp M, Terada K, Wilson A, et al. Kinetics and viral protein specificity of the cytotoxic T lymphocyte response in healthy adults immunized with live attenuated varicella vaccine. J Infect Dis 1992; 165:852-8.
18. Sadzot-Delvaux C, Kinchington P, Rentier B, Arvin AM. Recognition of the latency-associated immediate early protein IE63 of varicellazoster virus by human memory T lymphocytes. J Immunol 1997; 159:2802-6.
19. Levin MJ, Smith JG, Kaufhold RM, et al. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis 2003; 188:1336-44.
20. Arvin AM, Koropchak CM, Wittek AE. Immunologic evidence for reinfection with varicella-zoster virus. J Infect Dis 1983; 148:200-5.
21. Gershon AA, Steinberg SP, Gelb L. Clinical reinfection with varicella-zoster virus. J Infect Dis 1984; 149:137-42.
22. Gourley TS, Wherry EJ, Masopust D, Ahmed R. Generation and maintenance of immunological memory. Semin Immunol 2004; 16:323-33.
23. Gershon AA, LaRussa P, Hardy I, Steinberg S, Silverstein S. Varicella vaccine: the American experience. J Infect Dis 1992; 166(Suppl 1):S63-8.
24. Bergen RE, Diaz PS, Arvin AM. The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content. J Infect Dis 1990; 162:1049-54.
25. Watson B, Piercy S, Soppas D, et al. The effect of decreasing amounts of live virus, while antigen content remains constant, on immunogenicity of Oka/Merck varicella vaccine. J Infect Dis 1993; 168:1356-60.
26. Watson B. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine. J Infect Dis 2008; 197(Suppl 2):S143-6 (in this supplement).
27. Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention. Recommendations of the ACIP on varicella immunization. Available at: http://www.cdc.gov/vaccines/recs/acip/default.htm. Accessed 16 November 2007.